Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Cinclus Pharma Holding AB - Filing #5879291

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Reserve of exchange differences on translation	—	—	28 667 SEK	—	—	—	—	—	—	26 004 SEK	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	—	546,000 SEK	—	—	—	—	—	—	322,000 SEK	—	—
Current assets	—	—	600 467 SEK	—	—	—	—	—	—	94 091 SEK	—	—
Non-current liabilities	—	—	190,000 SEK	—	—	—	—	—	—	6 790 SEK	—	—
Current liabilities	—	—	45 493 SEK	—	—	—	—	—	—	164 422 SEK	—	—
Profit (loss)	– SEK	168 031 SEK	—	– SEK	– SEK	168 031 SEK	– SEK	– SEK	215 118 SEK	—	215 118 SEK	– SEK
Other comprehensive income	– SEK	2 664 SEK	—	2 664 SEK	– SEK	– SEK	– SEK	– SEK	9 167 SEK	—	– SEK	9 167 SEK
Comprehensive income	– SEK	165 367 SEK	—	2 664 SEK	– SEK	168 031 SEK	– SEK	– SEK	205 951 SEK	—	215 118 SEK	9 167 SEK